John J. Abel Award in Pharmacology

John J. Abel Award in Pharmacology. This prestigious award is presented annually by the American Society for Pharmacology and Experimental Therapeutics (ASPET) to recognize and stimulate outstanding, original research in pharmacology by early-career scientists. Named in honor of John Jacob Abel, a founding father of modern pharmacology in the United States, it is one of the oldest and most distinguished awards in the field. The award highlights exceptional contributions to the understanding of drug action and therapeutic mechanisms.

History and establishment

The award was established in 1947 by a group of pharmaceutical companies, including Eli Lilly and Company, to honor the legacy of John Jacob Abel. Abel was a pioneering figure who founded the first department of pharmacology in the U.S. at the University of Michigan and later at Johns Hopkins University, and he also launched the Journal of Pharmacology and Experimental Therapeutics. The creation of the award coincided with a period of rapid growth in pharmacological research following World War II, aiming to encourage young scientists. Its establishment was formally announced during a meeting of the American Society for Pharmacology and Experimental Therapeutics, solidifying its role in the society's mission to advance the discipline.

Award criteria and selection process

Eligibility for the award is restricted to investigators who are early in their independent research careers, typically within seven years of their first faculty appointment. Candidates must be members of the American Society for Pharmacology and Experimental Therapeutics and are nominated by their peers or institutions based on their original research contributions. The selection is made by a committee appointed by the ASPET Board of Trustees, which rigorously evaluates the nominee's published work, its innovation, and its impact on the field of pharmacology. The process emphasizes the significance of the research in areas such as molecular pharmacology, neuropharmacology, or clinical pharmacology.

Notable recipients

Since its inception, the award has been conferred upon many scientists who later achieved great prominence in biomedical research. Early recipients include Julius Axelrod (1955), who later won the Nobel Prize in Physiology or Medicine for his work on neurotransmitters. Other distinguished awardees are Robert F. Furchgott (1964), a Nobel laureate for the discovery of nitric oxide as a signaling molecule, and Solomon H. Snyder (1971), renowned for his research on opioid receptors. More recent recipients, such as Nancy C. Andreasen (1976) and David J. Julius (1996), have also made transformative contributions to psychiatry and sensory biology, respectively, demonstrating the award's role in identifying future leaders.

Significance and impact

The John J. Abel Award is highly significant within the global pharmacological community, serving as a major career milestone that provides recognition and visibility for emerging scientists. It has helped launch the careers of numerous researchers who have gone on to lead major departments at institutions like Stanford University, the National Institutes of Health, and the Mayo Clinic. The award underscores the importance of fundamental pharmacological research in driving therapeutic innovation, influencing drug discovery for conditions ranging from cardiovascular disease to mental health disorders. Its legacy is evident in the continued high caliber of its recipients and their ongoing contributions to science and medicine.

Award administration and sponsors

The award is administered by the American Society for Pharmacology and Experimental Therapeutics, which oversees the nomination process, committee selection, and presentation ceremony, typically held at the annual ASPET Annual Meeting at Experimental Biology. Historically, the award was funded by an endowment from several founding pharmaceutical sponsors, including Eli Lilly and Company, Abbott Laboratories, and Parke-Davis. Today, it is supported by the ASPET Award Endowment Fund, with sustained contributions from various corporate partners and individual donors within the pharmacological sciences community to ensure its continuation.

Category:American Society for Pharmacology and Experimental Therapeutics Category:Medical and health awards Category:Science and technology awards